Search

1751. Income of working-age veterans receiving disability compensation

Author(s):

Bass, Elizabeth, (Economist), author
Golding, Heidi L. W., author

Publication:

[Washington, D.C.] : Congressional Budget Office, December 2023

Subject(s):

Persons with Disabilities -- statistics & numerical data
Income -- statistics & numerical data
Insurance, Disability -- statistics & numerical data
Veterans -- statistics & numerical data
United States

1752. Federal budgetary effects of the activities of the Center for Medicare & Medicaid Innovation

Author(s):

Cohen, Michael, (Of Congressional Budget Office), author
Hall, Cornelia, author
Matthews, Rachel, (Of Health Management Associates), author
Robillard, Lara, author
Hale, Jessica, author
Zhang, Katie, author

Publication:

[Washington, D.C.] : Congressional Budget Office, September 2023

Subject(s):

Budgets -- trends
Federal Government
Models, Economic
United States
Center for Medicare & Medicaid Innovation (U.S.)

1753. Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, October 19, 2023

Subject(s):

Access to Primary Care -- statistics & numerical data
Government Regulation
Health Inequities
Health Promotion -- economics
Medicare
Primary Prevention
United States

1754. Mental health services: State should collect ongoing feedback to ensure overseas employees’ needs are being met : report to congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, October 2023

Subject(s):

Foreign Professional Personnel -- psychology
Government Employees -- psychology
Government Regulation
Legislation, Medical
Mental Health Services
Workload
United States
United States. Agency for International Development

1755. Public health preparedness: Building and maintaining infrastructure beyond the COVID-19 pandemic : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, November 2023

Subject(s):

Disaster Planning
Government Regulation
Legislation, Medical
Public Health
Public Health Infrastructure
COVID-19
United States

1756. FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Government Regulation
Health Policy
Tobacco Control
Tobacco Industry -- legislation & jurisprudence
United States
United States. Food and Drug Administration

1757. National uninsured rate remained unchanged in the second quarter of 2023

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, November 2023

Subject(s):

Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Medically Uninsured -- statistics & numerical data
United States

1758. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

1759. Review of Medicare administrative contractor information security program evaluations for fiscal year 2022

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023

Subject(s):

Computer Security -- standards
Government Regulation
Medicare -- organization & administration
Quality Control
United States

1760. New Jersey could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Disaster Planning -- standards
Government Regulation
Guideline Adherence
Infection Control -- standards
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- standards
Safety Management -- standards
New Jersey

1761. CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023

Subject(s):

COVID-19 Testing -- instrumentation
Equipment Failure Analysis
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

1762. Pennsylvania implemented our prior audit recommendations for critical incidents involving Medicaid enrollees with developmental disabilities but should continue to take action to reduce unreported incidents

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023

Subject(s):

Developmental Disabilities
Government Regulation
Mandatory Reporting
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- standards
Safety Management -- standards
Pennsylvania

1763. Invisible children, invisible families: a blueprint for supporting the child care needs of American Indian and Alaska native families

Author(s):

Fabre, Barb, author
Grunewald, Rob, author
Smith, Linda K., author
Osborn, Caroline, (Of Bipartisan Policy Center), author

Publication:

Washington, DC : Bipartisan Policy Center, November 2023

Subject(s):

American Indian or Alaska Native
Child
Health Services Accessibility
Healthcare Disparities
Indigenous Peoples
Social Determinants of Health
United States

1764. Healthy eating Rx: improving nutrition through health care

Author(s):

Glickman, Dan, author
Frist, William H., author
Shalala, Donna E., author
Veneman, Ann Margaret, 1949- author

Publication:

Washington, DC : Bipartisan Policy Center, November 2023

Subject(s):

Diet, Healthy
Food Assistance
Government Regulation
Health Policy
Nutrition Policy
Nutrition Therapy
United States
Supplemental Nutrition Assistance Program (U.S.)

1765. Medicare cognitive assessments: utilization tripled between 2018 and 2022, but challenges remain : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, December 2023

Subject(s):

Alzheimer Disease
Government Regulation
Healthcare Disparities
Medicare
Mental Status and Dementia Tests -- statistics & numerical data
Neurocognitive Disorders
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

1766. Reformulating drug products that contain carbomers manufactured with benzene: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2023

Subject(s):

Benzene
Drug Compounding
Drug Industry
Government Regulation
Legislation, Drug
Pharmaceutical Preparations
United States

1767. Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2023

Subject(s):

Biological Products
Data Collection
Decision Making
Drug Industry
Legislation, Drug
Government Regulation
Pharmaceutical Preparations
Registries
United States

1768. Understanding the impacts of OS-PCORTF projects on data capacity: an interim qualitative assessment

Author(s):

Evans, Emily, (Of Office of the Assistant Secretary for Planning and Evaluation), author
Srinivasan, Mithuna, author
Correa, Kiran, author
Ryan, Sofia, author
Harmsen, Mikaela, author
Lumsden, Susan, author
Dullabh, Prashila, author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation ; [Chicago, Illinois] : NORC, September 2023

Subject(s):

Data Collection
Evidence-Based Medicine
Patient-Centered Care
Qualitative Research
United States

1769. Changes in the list prices of prescription drugs, 2017-2023

Author(s):

Bosworth, Arielle, author
Sheingold, Steven, author
Finegold, Kenneth, author
Sayed, Bisma A., author
De Lew, Nancy, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 6, 2023

Subject(s):

Drug Costs -- trends
Prescription Drugs -- economics
United States

1770. CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2024

Subject(s):

COVID-19
Data Collection
Government Regulation
Mandatory Reporting
Nursing Homes
United States
Centers for Disease Control (U.S.)

1771. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023

Subject(s):

Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

1772. Medicaid Managed Care: Rapid spending growth in state directed payments needs enhanced oversight and transparency : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, December 2023

Subject(s):

Government Regulation
Health Expenditures
Managed Care Programs
Medicaid
State Health Plans
United States
Centers for Medicare & Medicaid Services (U.S.)

1773. Direct-to-consumer prescription drug advertisements: presentation of the major statement in a clear, conspicuous, and neutral manner in advertisements in television and radio format final rule : questions and answers : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2023

Subject(s):

Direct-to-Consumer Advertising -- legislation & jurisprudence
Drug Industry
Government Regulation
Legislation, Drug
Prescription Drugs
United States

1774. Registration and listing of cosmetic product facilities and products: guidance for industry

Publication:

Silver Spring, MD : Office of the Chief Scientist, December 2023

Subject(s):

Cosmetics -- legislation & jurisprudence
Drug Industry
Government Regulation
Legislation, Drug
Manufacturing and Industrial Facilities -- legislation & jurisprudence
United States

1775. Rare diseases: considerations for the development of drugs and biological products : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2023

Subject(s):

Biological Products
Drug Development
Drug Industry
Government Regulation
Rare Diseases -- drug therapy
United States

1776. Key strategies that states used for managing Medicaid and marketplace enrollment during the COVID-19 PHE

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

COVID-19
Eligibility Determination -- organization & administration
Government Regulation
Health Insurance Exchanges
Medicaid -- organization & administration
State Health Planning and Development Agencies
United States

1777. New York did not ensure that a managed care organization complied with requirements for denying prior authorization requests

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023

Subject(s):

Government Regulation
Managed Care Programs -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Medicaid -- organization & administration
Prior Authorization -- economics
New York

1778. Reimbursement mechanisms and challenges in team-based behavioral health care

Author(s):

Huber, Ben, (Of RTI International), author
Belenky, Nadya, author
Watson, Colleen, author
Gibbons, Brent, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office Of Behavioral Health, Disability, and Aging Policy, October 17, 2023

Subject(s):

Mental Health Services -- economics
Patient Care Team -- economics
Reimbursement Mechanisms
United States

1779. Behavioral health diagnoses and treatment services for children and youth involved with the child welfare system

Author(s):

Radel, Laura, author
Lieff, Sarah, author
Couzens, Chandra, author
Ali, Mir M., (Health economist) author
West, Kristina, (Of Office of the Assistant Secretary for Planning and Evaluation), author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, October 2023

Subject(s):

Adolescent
Child
Child Behavior Disorders -- drug therapy
Child Welfare -- statistics & numerical data
Mental Health Services -- statistics & numerical data
Prescription Drug Overuse -- statistics & numerical data
Psychotropic Drugs -- therapeutic use
State Government
United States

1780. Projected impacts for Black Medicare enrollees

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, September 25, 2023

Subject(s):

Black or African American
Cost Savings
Drug Costs -- legislation & jurisprudence
Forecasting
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
United States
United States.

1781. Review of personnel shortages in federal health care programs during the COVID-19 pandemic

Publication:

Washington, D.C. : Pandemic Response Accountability Committee, September 2023

Subject(s):

COVID-19 -- economics
Government Programs
Government Regulation
Health Workforce -- statistics & numerical data
United States
United States. Department of Defense
United States. Department of Health and Human Services
United States. Department of Justice
United States. Department of Veterans Affairs

1782. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, September 2017

Subject(s):

Anti-Bacterial Agents -- adverse effects
Commerce -- standards
Drug Residues -- standards
Fishes
Food Contamination -- prevention & control
Food Safety
Food Supply -- standards
Hazard Analysis and Critical Control Points
Seafood
Asia
Canada
United States
United States. Department of Agriculture
United States. Food and Drug Administration

1783. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, September 2017

Subject(s):

Employment -- statistics & numerical data
Poverty -- statistics & numerical data
Public Assistance -- statistics & numerical data
Public Assistance -- trends
United States

1784. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, November 1, 2017

Subject(s):

Government Agencies
Interinstitutional Relations
Radiation Effects
Radiation, Ionizing
Research
United States
United States. Department of Energy
United States. Environmental Protection Agency
United States. Food and Drug Administration
U.S. Nuclear Regulatory Commission.

1785. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, October 2017

Subject(s):

Federal Government
Health Benefit Plans, Employee -- statistics & numerical data
Insurance Carriers
United States

1786. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, November 29, 2017

Subject(s):

Clinical Competence
Government Regulation
Hospitals, Veterans
Patient Safety
Quality of Health Care
United States
United States. Veterans Health Administration

1787. Food safety: FDA continues to evaluate and respond to business concerns about the produce rule : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, November 2017

Subject(s):

Commerce
Food Contamination
Food Safety
Fruit
Vegetables
United States
United States. Food and Drug Administration

1788. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, November 2017

Subject(s):

Benchmarking
Consumer Behavior
Costs and Cost Analysis
Health Insurance Exchanges -- economics
Insurance, Health -- economics
United States
United States.

1789. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, November 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
United States
National Institutes of Health (U.S.)

1790. Medicare Part B: Medicare represented at least half of the market for 22 of the 84 most expensive drugs in 2015 : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, December 2017

Subject(s):

Drug Costs
Health Care Sector
Health Expenditures
Medicare Part B -- economics
United States

1791. Social Security disability: additional measures and evaluation needed to enhance accuracy and consistency of hearings decisions : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, December 2017

Subject(s):

Disability Evaluation
Social Security -- legislation & jurisprudence
United States
United States. Social Security Administration